Iantrek Raises $42 Million Series C To Launch Alloflo™ Uveo, A Breakthrough Interventional Glaucoma Therapy
Aug 20 (Reuters) -
Further company coverage: [ ]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.